Efficacy and Safety of Oral Fosfomycin for Asymptomatic Bacteriuria in Kidney Transplant Recipients: Results from a Spanish Multicenter Cohort | Zendy

María RuizRuigómez | Zendy; Mario FernándezRuiz | Zendy; José Tiago Silva | Zendy; Elisa Vidal | Zendy; Julia Origüen | Zendy; Antonia CalvoCano | Zendy; Enrique Luna | Zendy; Esperanza Merino | Zendy; Domingo Hernández | Zendy; Cristina JirondaGallegos | Zendy; Rosa Escudero-Sánchez | Zendy; Francesca Gioia | Zendy; Antonio Moreno | Zendy; Cristina Roca-Oporto | Zendy; Elisa Cordero | Zendy; Darío Janeiro | Zendy; Beatriz SánchezSobrino | Zendy; M. Montero | Zendy; Dolores RedondoPachón | Zendy; Francisco Javier Candel | Zendy; Isabel PérezFlores | Zendy; Carlos Armiñanzas | Zendy; Claudia GonzalezRico | Zendy; María Carmen Fariñas | Zendy; Emilio Rodrigo | Zendy; Belén Loeches | Zendy; María O. LópezOliva | Zendy; Miguel Montejo | Zendy; Ricardo Lauzurica | Zendy; Juan Pablo Horcajada | Zendy; Julio Pascual | Zendy; Amado Andrés | Zendy; José María Aguado | Zendy; Francisco LópezMedrano | Zendy

Open Access

Efficacy and Safety of Oral Fosfomycin for Asymptomatic Bacteriuria in Kidney Transplant Recipients: Results from a Spanish Multicenter Cohort

Author(s) -

María RuizRuigómez,

Mario FernándezRuiz,

José Tiago Silva,

Elisa Vidal,

Julia Origüen,

Antonia CalvoCano,

Enrique Luna,

Esperanza Merino,

Domingo Hernández,

Cristina JirondaGallegos,

Rosa Escudero-Sánchez,

Francesca Gioia,

Antonio Moreno,

Cristina Roca-Oporto,

Elisa Cordero,

Darío Janeiro,

Beatriz SánchezSobrino,

M. Montero,

Dolores RedondoPachón,

Francisco Javier Candel,

Isabel PérezFlores,

Carlos Armiñanzas,

Claudia GonzalezRico,

María Carmen Fariñas,

Emilio Rodrigo,

Belén Loeches,

María O. LópezOliva,

Miguel Montejo,

Ricardo Lauzurica,

Juan Pablo Horcajada,

Julio Pascual,

Amado Andrés,

José María Aguado,

Francisco LópezMedrano

Publication year - 2021

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02267-20

Subject(s) - fosfomycin , medicine , asymptomatic , asymptomatic bacteriuria , kidney transplantation , bacteriuria , transplantation , cohort study , cohort , kidney transplant , intensive care medicine , urinary system , antibiotics , microbiology and biotechnology , biology

Current guidelines recommend against systematic screening for or treating asymptomatic bacteriuria (AB) among kidney transplant (KT) recipients, although the evidence regarding episodes occurring early after transplantation or in the presence of anatomical abnormalities is inconclusive. Oral fosfomycin may constitute a good option for the treatment of posttransplant AB, particularly due to the emergence of multidrug-resistant (MDR) uropathogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research